Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1980 2
1981 3
1982 6
1983 3
1984 8
1985 11
1986 11
1987 18
1988 10
1989 25
1990 30
1991 38
1992 39
1993 53
1994 45
1995 46
1996 59
1997 75
1998 63
1999 100
2000 133
2001 126
2002 142
2003 195
2004 276
2005 336
2006 367
2007 458
2008 541
2009 629
2010 718
2011 868
2012 1071
2013 1277
2014 1519
2015 1771
2016 1788
2017 1950
2018 2106
2019 2582
2020 3123
2021 3464
2022 3918
2023 3981
2024 4690
2025 3031

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37,209 results

Results by year

Filters applied: . Clear all
Page 1
Life's Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China.
Li M, Xu M, Ding Y, Lin H, Qin G, Wang T, Xu Y, Chen Y, Wang S, Zhao Z, Zheng J, Yan L, Shi L, Gao Z, Chen L, Zeng T, Hu R, Ye Z, Yu X, Chen G, Su Q, Mu Y, Tang X, Wan Q, Wang G, Shen F, Gu X, Luo Z, Qin Y, Chen L, Hou X, Huo Y, Li Q, Qiao H, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Zhao J, Ning G, Lu J, Wang W, Bi Y. Li M, et al. Among authors: yu x. Cardiovasc Diabetol. 2025 May 9;24(1):197. doi: 10.1186/s12933-025-02735-3. Cardiovasc Diabetol. 2025. PMID: 40346555 Free PMC article.
Microneedle Patch for In Situ Neutrophil Monitoring.
Lu Z, Cai R, Xie T, Zhao S, Juengpanich S, Topatana W, Li S, Cao J, Hu J, Chen T, Chen J, Yu J, Sheng T, Zhang W, Wang H, You J, Shan Y, Sun Y, Shen R, Zhao Z, Ji K, Gao Z, Yu X, Cai X, Gu Z, Zhang Y, Chen M. Lu Z, et al. Among authors: yu x. Adv Sci (Weinh). 2025 Jun;12(23):e2417801. doi: 10.1002/advs.202417801. Epub 2025 May 8. Adv Sci (Weinh). 2025. PMID: 40345175 Free PMC article.
Come get dissolved in PML bodies.
Yu X, Zhang H. Yu X, et al. Nat Chem Biol. 2025 Jul 1. doi: 10.1038/s41589-025-01960-x. Online ahead of print. Nat Chem Biol. 2025. PMID: 40593328 No abstract available.
New advances in the treatment of EGFR exon20ins mutant advanced NSCLC.
Yuan C, Yu JY, Zeng CX, Wang MC, Zhang S, Huang YB, Yu XS, Kong FM, Chen LW. Yuan C, et al. Among authors: yu xs. Am J Cancer Res. 2025 Apr 25;15(4):1852-1873. doi: 10.62347/WTMU5537. eCollection 2025. Am J Cancer Res. 2025. PMID: 40371155 Free PMC article. Review.
Advancing research on regulatory autoantibodies targeting GPCRs: Insights from the 5th international symposium.
Cabral-Marques O, Schimke LF, Moll G, Filgueiras IS, Nóbile AL, Adri AS, do Vale FYN, Usuda JN, Corrêa YLG, Albuquerque D, Nava RG, Santos RS, Dias HD, Silva HF, Marconi PB, Catar R, Adu-Gyamfi M, Wang P, Khan TA, Hackel AM, Leheis A, Stähle A, Müller A, Schmidt C, Radunovic C, Adjailia EB, Grasshoff H, Humrich JY, Menz J, Fourlakis K, Winziers M, Jäpel M, Wegner MV, Lamprecht P, Nieberding R, Akbarzadeh R, Arnold S, Jendrek S, Klapa S, Augustin S, Biedermann S, Schinke S, Scheerer P, Endres M, Schulze-Forster K, Paul F, Yu X, Sotzny F, Sakmar TP, Banasik M, Haghikia A, Hoffmann MH, Veprintsev D, Witte T, Dalmolin RJS, Ochs HD, Heidecke H, Scheibenbogen C, Shoenfeld Y, Riemekasten G. Cabral-Marques O, et al. Among authors: yu x. Autoimmun Rev. 2025 Jun 19;24(9):103855. doi: 10.1016/j.autrev.2025.103855. Online ahead of print. Autoimmun Rev. 2025. PMID: 40543860 Free article. Review.
37,209 results
You have reached the last available page of results. Please see the User Guide for more information.